AG-13958

AG-13958 (AG-013958), a potent VEGFR tyrosine kinase inhibitor, is used for treatment of choroidal neovascularization associated with age-related macular degeneration (AMD).

$ 2,794.80 2794.8 USD $ 2,794.80

2,794.80 €

This combination does not exist.

Terms and Conditions
30-day money-back guarantee
Shipping: 2-3 Business Days

Internal Reference: cell25sk38689
Size: 100mg